Protandim®
(www.Protandim.com),
the only product clinically proven to slow the progressive rate of
aging, announced today that it is entering the multi-billion dollar
network marketing industry via independent distributorships offered by
the product's maker, LifeVantage
Corporation (OTCBB:LFVN). The company will continue to
have a retail presence, in addition to the independent distributorships.
David Brown, LifeVantage President and CEO said, "Network
marketing is by far the fastest growing sales channel for dietary
supplements. We know that the Protandim® story
is one that resonates with customers and makes them want to share the
product's tremendous benefits with others. In
the past, we have had many requests for independent distributorship
opportunities with the Company. Until now that option was not available."
Brown continued, "This latest step in our
commitment to introduce Protandim® into
multiple sales channels is marked by the success we have had in
recruiting successful network marketing professionals and distributors
who have previously been instrumental in the success of some of the
largest network marketing companies in the industry."
Tom Aarts, Managing Director of Nutrition Business Advisors, and
Co-Founder of The Nutrition Business Journal endorses the Company's
decision to pursue the network marketing channel. "Over
$100 billion dollars a year are spent fighting aging. In the U.S. alone,
the network marketing industry accounts for $7.9 billion in sales. I
believe Protandim will do exceptionally well with the network marketing
business model, because this model allows the distributors the
opportunity to fully explain the product's
benefits and uses, a key advantage of this distribution model,"
he said.
In commenting further on the Company's move,
Brown added, "In addition to offering a
product that is unparalleled in any sales channel, we have worked with
InfoTrax Systems, a leading developer of commission tracking software,
to develop a commission plan that we believe will be one of the best in
the industry. We are combining the enthusiasm that our product inspires,
with the opportunity to build a successful home-based business in the
trillion dollar health care industry. With the benefits and science of
Protandim®, we have the opportunity to be the
next great success story in an industry known for producing such
fast-growing companies as Mona Vie, Xango and others."
About
Protandim®
Protandim® is a
groundbreaking, clinically proven solution for healthy aging. This
patented anti-oxidant therapy is 1000's of
times more powerful than red wine, oranges, blueberries, acai juice or
other popular anti-oxidant supplements. Protandim works by increasing
the body's natural anti-oxidant protection at
the cellular level, triggering cells to produce naturally occurring
protective antioxidant enzymes such as super oxide dismutase (SOD),
catalase, and glutathione.
A peer-reviewed scientific study shows that after 30 days of taking
Protandim, free radicals decreased an average of 40 percent, slowing the
progressive aging factors to the level of a 20 year old. Protandim is
currently the subject of over 20 scientific studies at leading
universities and research institutes. For more information, please visit
the Protandim® product web site at www.Protandim.com
or contact Jan Strode at (619) 890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science
based, natural products company, dedicated to helping people reach their
health and wellness goals through science-based solutions to oxidative
stress. Founded in 2003 and based in San Diego, CA, LifeVantage develops
nutraceutical products, including Protandim
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.LifeVantage.com
or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate,""believe,""could,""should,""estimate,""expect,""intend,""may,""predict,""project,""plan,""target" and
similar terms and phrases, including references to assumptions, to
identify forward-looking statements.These forward-looking
statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's
ability to protect our intellectual property rights and the value of our
product.These and other risk factors are discussed in greater
detail in the Company's Annual Report on Form
10-KSB under the caption "Risk Factors",
and in other documents filed by the Company from time to time with the
Securities and Exchange Commission.The Company cautions
investors not to place undue reliance on the forward-looking statements
contained in this document.All forward-looking statements are
based on information currently available to the Company on the date
hereof, and the Company undertakes no obligation to revise or update
these forward-looking statements to reflect events or circumstances
after the date of this document, except as required by law.
These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 or Jean Golden at
612-385-2324 for interviews, photography, and other requests.
For LifeVantage Corporation:
Jan Strode, 619-890-4040
Jean
Golden, 612-385-2324